Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00028
|
|||||
Drug Name |
Etilefrine
|
|||||
Synonyms |
2-Ethylamino-1-(3-hydroxyphenyl)ethanol Hydrochloride; 3-(2-(Ethylamino)-1-hydroxyethyl)phenol hydrochloride; 3-[2-(ethylamino)-1-hydroxyethyl]phenol hydrochloride; 534-87-2; 943-17-9; Apocretin; Circupon; Effontil; Effortilvet; Ethyl adrianol; Ethylephrine hydrochloride; Eti-Puren; Etilefrin Hydrochloride; Etilefrine HCl; Etilefrine hydrochloride; Etilefrine hydrochloride (TN); Funasol; Kertasin; Phetanol; Phetasin; Pulsamin; Tonus-Forte; Updormin; dl-Effortil hydrochloride; dl-Etilefrin hydrochloride; dl-N-Ethylnorphenylephrine h
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Hypotension [ICD11: BA2Z] | Withdrawn | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C10H16ClNO2
|
|||||
Canonical SMILES |
CCNCC(C1=CC(=CC=C1)O)O.Cl
|
|||||
InChI |
InChI=1S/C10H15NO2.ClH/c1-2-11-7-10(13)8-4-3-5-9(12)6-8;/h3-6,10-13H,2,7H2,1H3;1H
|
|||||
InChIKey |
KTNROWWHOBZQGK-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 164652
|
|||||
Pharmaceutical Properties | Molecular Weight | 217.69 | Topological Polar Surface Area | 52.5 | ||
Heavy Atom Count | 14 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 3 | |||
PubChem CID | ||||||
ChEBI ID |
ChEBI:31582
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | OCT-3 | Transporter Info | Organic cation transporter 3 | Substrate | [2] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | OCT-3 | Transporter Info | Km = 2800 microM | Chinese hamster ovary (CHO) cells-OCT3 | [2] | |
References | ||||||
1 | DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (id: DB08985) | |||||
2 | Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem Pharmacol. 2005 Dec 5;70(12):1851-60. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.